Efficacy and Safety of Meloxicam (Mobicox®) in Mexican Population With Rheumatic Diseases

Boehringer Ingelheim

Status: Completed

Conditions: Osteoarthritis

Study type: Observational

Funder types: Industry

Identifiers

NCT02184039

107.264

Details and patient eligibility

About

Study to evaluate the efficacy and safety of meloxicam (Mobicox®) in Mexican population with rheumatic diseases.

Enrollment: 12,687 patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• none

Exclusion criteria

• Hypersensitivity to meloxicam or to other NSAIDS
• History of asthma, angioedema or urticaria secondary to NSAIDS
• Pregnancy or lactation
• Recent or current history of peptic ulcer disease, severe renal failure, severe hepatic failure
• Age below of 12 years.